Global 2019-nCoV Assay Kit Market Research Report 2021

Publisher Name :
Date: 23-Mar-2021
No. of pages: 132
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Nucleic Acid Detection Kit

- Antibody Detection Kit

Segment by Application

- Designated Hospital

- Diagnostic Center

- Scientific Research

- Port of Entry

- Individual

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Roche

- Seegene

- PharmACT

- Everlywell

- Biopanda

- Mylab Discovery

- Integrated DNA Technologies

- Cosara Diagnostics

- Solgent

- Kogene Biotech

- SD Biosensor

- Biosewoom

- Shanghai ZJ Bio-Tech

- Shanghai Geneodx Biotech

- INNOVITA

- Genomics Biotech (Wuhan)

- Zhongshan Daan Gene

- Sanaure

- Shanghai Bio-Germ

- Guangzhou Wonfo Bio-Tech

- Chengdu Boaojing Bio-Tech

- Beijing XABT

- Bioscience(Chongqing) Bio-Tech

- Maccura Bio-Tech

- Xiamen InnoDx

- Guangdong Hecin-Scientific

- Wuhan Easydiagnosis Biomedicine

- Curative

- Biolidics

Global 2019-nCoV Assay Kit Market Research Report 2021

Table of Contents
1 2019-nCoV Assay Kit Market Overview
1.1 Product Overview and Scope of 2019-nCoV Assay Kit
1.2 2019-nCoV Assay Kit Segment by Type
1.2.1 Global 2019-nCoV Assay Kit Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Nucleic Acid Detection Kit
1.2.3 Antibody Detection Kit
1.3 2019-nCoV Assay Kit Segment by Application
1.3.1 2019-nCoV Assay Kit Sales Comparison by Application: (2021-2027)
1.3.2 Designated Hospital
1.3.3 Diagnostic Center
1.3.4 Scientific Research
1.3.5 Port of Entry
1.3.6 Individual
1.3.7 Others
1.4 Global 2019-nCoV Assay Kit Market Size Estimates and Forecasts
1.4.1 Global 2019-nCoV Assay Kit Revenue 2016-2027
1.4.2 Global 2019-nCoV Assay Kit Sales 2016-2027
1.4.3 2019-nCoV Assay Kit Market Size by Region: 2016 Versus 2021 Versus 2027
2 2019-nCoV Assay Kit Market Competition by Manufacturers
2.1 Global 2019-nCoV Assay Kit Sales Market Share by Manufacturers (2016-2021)
2.2 Global 2019-nCoV Assay Kit Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 2019-nCoV Assay Kit Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 2019-nCoV Assay Kit Manufacturing Sites, Area Served, Product Type
2.5 2019-nCoV Assay Kit Market Competitive Situation and Trends
2.5.1 2019-nCoV Assay Kit Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 2019-nCoV Assay Kit Players Market Share by Revenue
2.5.3 Global 2019-nCoV Assay Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 2019-nCoV Assay Kit Retrospective Market Scenario by Region
3.1 Global 2019-nCoV Assay Kit Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global 2019-nCoV Assay Kit Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America 2019-nCoV Assay Kit Market Facts & Figures by Country
3.3.1 North America 2019-nCoV Assay Kit Sales by Country
3.3.2 North America 2019-nCoV Assay Kit Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe 2019-nCoV Assay Kit Market Facts & Figures by Country
3.4.1 Europe 2019-nCoV Assay Kit Sales by Country
3.4.2 Europe 2019-nCoV Assay Kit Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 2019-nCoV Assay Kit Market Facts & Figures by Region
3.5.1 Asia Pacific 2019-nCoV Assay Kit Sales by Region
3.5.2 Asia Pacific 2019-nCoV Assay Kit Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America 2019-nCoV Assay Kit Market Facts & Figures by Country
3.6.1 Latin America 2019-nCoV Assay Kit Sales by Country
3.6.2 Latin America 2019-nCoV Assay Kit Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa 2019-nCoV Assay Kit Market Facts & Figures by Country
3.7.1 Middle East and Africa 2019-nCoV Assay Kit Sales by Country
3.7.2 Middle East and Africa 2019-nCoV Assay Kit Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global 2019-nCoV Assay Kit Historic Market Analysis by Type
4.1 Global 2019-nCoV Assay Kit Sales Market Share by Type (2016-2021)
4.2 Global 2019-nCoV Assay Kit Revenue Market Share by Type (2016-2021)
4.3 Global 2019-nCoV Assay Kit Price by Type (2016-2021)
5 Global 2019-nCoV Assay Kit Historic Market Analysis by Application
5.1 Global 2019-nCoV Assay Kit Sales Market Share by Application (2016-2021)
5.2 Global 2019-nCoV Assay Kit Revenue Market Share by Application (2016-2021)
5.3 Global 2019-nCoV Assay Kit Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Seegene
6.2.1 Seegene Corporation Information
6.2.2 Seegene Description and Business Overview
6.2.3 Seegene 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Seegene Product Portfolio
6.2.5 Seegene Recent Developments/Updates
6.3 PharmACT
6.3.1 PharmACT Corporation Information
6.3.2 PharmACT Description and Business Overview
6.3.3 PharmACT 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.3.4 PharmACT Product Portfolio
6.3.5 PharmACT Recent Developments/Updates
6.4 Everlywell
6.4.1 Everlywell Corporation Information
6.4.2 Everlywell Description and Business Overview
6.4.3 Everlywell 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Everlywell Product Portfolio
6.4.5 Everlywell Recent Developments/Updates
6.5 Biopanda
6.5.1 Biopanda Corporation Information
6.5.2 Biopanda Description and Business Overview
6.5.3 Biopanda 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Biopanda Product Portfolio
6.5.5 Biopanda Recent Developments/Updates
6.6 Mylab Discovery
6.6.1 Mylab Discovery Corporation Information
6.6.2 Mylab Discovery Description and Business Overview
6.6.3 Mylab Discovery 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Mylab Discovery Product Portfolio
6.6.5 Mylab Discovery Recent Developments/Updates
6.7 Integrated DNA Technologies
6.6.1 Integrated DNA Technologies Corporation Information
6.6.2 Integrated DNA Technologies Description and Business Overview
6.6.3 Integrated DNA Technologies 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Integrated DNA Technologies Product Portfolio
6.7.5 Integrated DNA Technologies Recent Developments/Updates
6.8 Cosara Diagnostics
6.8.1 Cosara Diagnostics Corporation Information
6.8.2 Cosara Diagnostics Description and Business Overview
6.8.3 Cosara Diagnostics 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Cosara Diagnostics Product Portfolio
6.8.5 Cosara Diagnostics Recent Developments/Updates
6.9 Solgent
6.9.1 Solgent Corporation Information
6.9.2 Solgent Description and Business Overview
6.9.3 Solgent 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Solgent Product Portfolio
6.9.5 Solgent Recent Developments/Updates
6.10 Kogene Biotech
6.10.1 Kogene Biotech Corporation Information
6.10.2 Kogene Biotech Description and Business Overview
6.10.3 Kogene Biotech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Kogene Biotech Product Portfolio
6.10.5 Kogene Biotech Recent Developments/Updates
6.11 SD Biosensor
6.11.1 SD Biosensor Corporation Information
6.11.2 SD Biosensor 2019-nCoV Assay Kit Description and Business Overview
6.11.3 SD Biosensor 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.11.4 SD Biosensor Product Portfolio
6.11.5 SD Biosensor Recent Developments/Updates
6.12 Biosewoom
6.12.1 Biosewoom Corporation Information
6.12.2 Biosewoom 2019-nCoV Assay Kit Description and Business Overview
6.12.3 Biosewoom 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Biosewoom Product Portfolio
6.12.5 Biosewoom Recent Developments/Updates
6.13 Shanghai ZJ Bio-Tech
6.13.1 Shanghai ZJ Bio-Tech Corporation Information
6.13.2 Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
6.13.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Shanghai ZJ Bio-Tech Product Portfolio
6.13.5 Shanghai ZJ Bio-Tech Recent Developments/Updates
6.14 Shanghai Geneodx Biotech
6.14.1 Shanghai Geneodx Biotech Corporation Information
6.14.2 Shanghai Geneodx Biotech 2019-nCoV Assay Kit Description and Business Overview
6.14.3 Shanghai Geneodx Biotech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Shanghai Geneodx Biotech Product Portfolio
6.14.5 Shanghai Geneodx Biotech Recent Developments/Updates
6.15 INNOVITA
6.15.1 INNOVITA Corporation Information
6.15.2 INNOVITA 2019-nCoV Assay Kit Description and Business Overview
6.15.3 INNOVITA 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.15.4 INNOVITA Product Portfolio
6.15.5 INNOVITA Recent Developments/Updates
6.16 Genomics Biotech (Wuhan)
6.16.1 Genomics Biotech (Wuhan) Corporation Information
6.16.2 Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Description and Business Overview
6.16.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Genomics Biotech (Wuhan) Product Portfolio
6.16.5 Genomics Biotech (Wuhan) Recent Developments/Updates
6.17 Zhongshan Daan Gene
6.17.1 Zhongshan Daan Gene Corporation Information
6.17.2 Zhongshan Daan Gene 2019-nCoV Assay Kit Description and Business Overview
6.17.3 Zhongshan Daan Gene 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zhongshan Daan Gene Product Portfolio
6.17.5 Zhongshan Daan Gene Recent Developments/Updates
6.18 Sanaure
6.18.1 Sanaure Corporation Information
6.18.2 Sanaure 2019-nCoV Assay Kit Description and Business Overview
6.18.3 Sanaure 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Sanaure Product Portfolio
6.18.5 Sanaure Recent Developments/Updates
6.19 Shanghai Bio-Germ
6.19.1 Shanghai Bio-Germ Corporation Information
6.19.2 Shanghai Bio-Germ 2019-nCoV Assay Kit Description and Business Overview
6.19.3 Shanghai Bio-Germ 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Shanghai Bio-Germ Product Portfolio
6.19.5 Shanghai Bio-Germ Recent Developments/Updates
6.20 Guangzhou Wonfo Bio-Tech
6.20.1 Guangzhou Wonfo Bio-Tech Corporation Information
6.20.2 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
6.20.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Guangzhou Wonfo Bio-Tech Product Portfolio
6.20.5 Guangzhou Wonfo Bio-Tech Recent Developments/Updates
6.21 Chengdu Boaojing Bio-Tech
6.21.1 Chengdu Boaojing Bio-Tech Corporation Information
6.21.2 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
6.21.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Chengdu Boaojing Bio-Tech Product Portfolio
6.21.5 Chengdu Boaojing Bio-Tech Recent Developments/Updates
6.22 Beijing XABT
6.22.1 Beijing XABT Corporation Information
6.22.2 Beijing XABT 2019-nCoV Assay Kit Description and Business Overview
6.22.3 Beijing XABT 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Beijing XABT Product Portfolio
6.22.5 Beijing XABT Recent Developments/Updates
6.23 Bioscience(Chongqing) Bio-Tech
6.23.1 Bioscience(Chongqing) Bio-Tech Corporation Information
6.23.2 Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
6.23.3 Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Bioscience(Chongqing) Bio-Tech Product Portfolio
6.23.5 Bioscience(Chongqing) Bio-Tech Recent Developments/Updates
6.24 Maccura Bio-Tech
6.24.1 Maccura Bio-Tech Corporation Information
6.24.2 Maccura Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
6.24.3 Maccura Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Maccura Bio-Tech Product Portfolio
6.24.5 Maccura Bio-Tech Recent Developments/Updates
6.25 Xiamen InnoDx
6.25.1 Xiamen InnoDx Corporation Information
6.25.2 Xiamen InnoDx 2019-nCoV Assay Kit Description and Business Overview
6.25.3 Xiamen InnoDx 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.25.4 Xiamen InnoDx Product Portfolio
6.25.5 Xiamen InnoDx Recent Developments/Updates
6.26 Guangdong Hecin-Scientific
6.26.1 Guangdong Hecin-Scientific Corporation Information
6.26.2 Guangdong Hecin-Scientific 2019-nCoV Assay Kit Description and Business Overview
6.26.3 Guangdong Hecin-Scientific 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.26.4 Guangdong Hecin-Scientific Product Portfolio
6.26.5 Guangdong Hecin-Scientific Recent Developments/Updates
6.27 Wuhan Easydiagnosis Biomedicine
6.27.1 Wuhan Easydiagnosis Biomedicine Corporation Information
6.27.2 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Description and Business Overview
6.27.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.27.4 Wuhan Easydiagnosis Biomedicine Product Portfolio
6.27.5 Wuhan Easydiagnosis Biomedicine Recent Developments/Updates
6.28 Curative
6.28.1 Curative Corporation Information
6.28.2 Curative 2019-nCoV Assay Kit Description and Business Overview
6.28.3 Curative 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.28.4 Curative Product Portfolio
6.28.5 Curative Recent Developments/Updates
6.29 Biolidics
6.29.1 Biolidics Corporation Information
6.29.2 Biolidics 2019-nCoV Assay Kit Description and Business Overview
6.29.3 Biolidics 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
6.29.4 Biolidics Product Portfolio
6.29.5 Biolidics Recent Developments/Updates
7 2019-nCoV Assay Kit Manufacturing Cost Analysis
7.1 2019-nCoV Assay Kit Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 2019-nCoV Assay Kit
7.4 2019-nCoV Assay Kit Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 2019-nCoV Assay Kit Distributors List
8.3 2019-nCoV Assay Kit Customers
9 2019-nCoV Assay Kit Market Dynamics
9.1 2019-nCoV Assay Kit Industry Trends
9.2 2019-nCoV Assay Kit Growth Drivers
9.3 2019-nCoV Assay Kit Market Challenges
9.4 2019-nCoV Assay Kit Market Restraints
10 Global Market Forecast
10.1 2019-nCoV Assay Kit Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Type (2022-2027)
10.1.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Type (2022-2027)
10.2 2019-nCoV Assay Kit Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Application (2022-2027)
10.2.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Application (2022-2027)
10.3 2019-nCoV Assay Kit Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Region (2022-2027)
10.3.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global 2019-nCoV Assay Kit Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global 2019-nCoV Assay Kit Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global 2019-nCoV Assay Kit Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers 2019-nCoV Assay Kit Covered in This Study
Table 5. Global 2019-nCoV Assay Kit Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global 2019-nCoV Assay Kit Sales Share by Manufacturers (2016-2021)
Table 7. Global 2019-nCoV Assay Kit Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global 2019-nCoV Assay Kit Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market 2019-nCoV Assay Kit Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers 2019-nCoV Assay Kit Manufacturing Sites and Area Served
Table 11. Manufacturers 2019-nCoV Assay Kit Product Type
Table 12. Global 2019-nCoV Assay Kit Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 2019-nCoV Assay Kit by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 2019-nCoV Assay Kit as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 2019-nCoV Assay Kit Sales by Region (2016-2021) & (K Units)
Table 16. Global 2019-nCoV Assay Kit Sales Market Share by Region (2016-2021)
Table 17. Global 2019-nCoV Assay Kit Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units)
Table 19. North America 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021)
Table 20. North America 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021)
Table 22. Europe 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units)
Table 23. Europe 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021)
Table 24. Europe 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific 2019-nCoV Assay Kit Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific 2019-nCoV Assay Kit Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific 2019-nCoV Assay Kit Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific 2019-nCoV Assay Kit Revenue Market Share by Region (2016-2021)
Table 30. Latin America 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units)
Table 31. Latin America 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021)
Table 32. Latin America 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa 2019-nCoV Assay Kit Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa 2019-nCoV Assay Kit Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa 2019-nCoV Assay Kit Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa 2019-nCoV Assay Kit Revenue Market Share by Country (2016-2021)
Table 38. Global 2019-nCoV Assay Kit Sales (K Units) by Type (2016-2021)
Table 39. Global 2019-nCoV Assay Kit Sales Market Share by Type (2016-2021)
Table 40. Global 2019-nCoV Assay Kit Revenue (Million US$) by Type (2016-2021)
Table 41. Global 2019-nCoV Assay Kit Revenue Share by Type (2016-2021)
Table 42. Global 2019-nCoV Assay Kit Price (US$/Unit) by Type (2016-2021)
Table 43. Global 2019-nCoV Assay Kit Sales (K Units) by Application (2016-2021)
Table 44. Global 2019-nCoV Assay Kit Sales Market Share by Application (2016-2021)
Table 45. Global 2019-nCoV Assay Kit Revenue (Million US$) by Application (2016-2021)
Table 46. Global 2019-nCoV Assay Kit Revenue Share by Application (2016-2021)
Table 47. Global 2019-nCoV Assay Kit Price (US$/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Roche 2019-nCoV Assay Kit Product
Table 52. Roche Recent Developments/Updates
Table 53. Seegene Corporation Information
Table 54. Seegene Description and Business Overview
Table 55. Seegene 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Seegene 2019-nCoV Assay Kit Product
Table 57. Seegene Recent Developments/Updates
Table 58. PharmACT Corporation Information
Table 59. PharmACT Description and Business Overview
Table 60. PharmACT 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. PharmACT 2019-nCoV Assay Kit Product
Table 62. PharmACT Recent Developments/Updates
Table 63. Everlywell Corporation Information
Table 64. Everlywell Description and Business Overview
Table 65. Everlywell 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Everlywell 2019-nCoV Assay Kit Product
Table 67. Everlywell Recent Developments/Updates
Table 68. Biopanda Corporation Information
Table 69. Biopanda Description and Business Overview
Table 70. Biopanda 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Biopanda 2019-nCoV Assay Kit Product
Table 72. Biopanda Recent Developments/Updates
Table 73. Mylab Discovery Corporation Information
Table 74. Mylab Discovery Description and Business Overview
Table 75. Mylab Discovery 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Mylab Discovery 2019-nCoV Assay Kit Product
Table 77. Mylab Discovery Recent Developments/Updates
Table 78. Integrated DNA Technologies Corporation Information
Table 79. Integrated DNA Technologies Description and Business Overview
Table 80. Integrated DNA Technologies 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Integrated DNA Technologies 2019-nCoV Assay Kit Product
Table 82. Integrated DNA Technologies Recent Developments/Updates
Table 83. Cosara Diagnostics Corporation Information
Table 84. Cosara Diagnostics Description and Business Overview
Table 85. Cosara Diagnostics 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Cosara Diagnostics 2019-nCoV Assay Kit Product
Table 87. Cosara Diagnostics Recent Developments/Updates
Table 88. Solgent Corporation Information
Table 89. Solgent Description and Business Overview
Table 90. Solgent 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Solgent 2019-nCoV Assay Kit Product
Table 92. Solgent Recent Developments/Updates
Table 93. Kogene Biotech Corporation Information
Table 94. Kogene Biotech Description and Business Overview
Table 95. Kogene Biotech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Kogene Biotech 2019-nCoV Assay Kit Product
Table 97. Kogene Biotech Recent Developments/Updates
Table 98. SD Biosensor Corporation Information
Table 99. SD Biosensor Description and Business Overview
Table 100. SD Biosensor 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. SD Biosensor 2019-nCoV Assay Kit Product
Table 102. SD Biosensor Recent Developments/Updates
Table 103. Biosewoom Corporation Information
Table 104. Biosewoom Description and Business Overview
Table 105. Biosewoom 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Biosewoom 2019-nCoV Assay Kit Product
Table 107. Biosewoom Recent Developments/Updates
Table 108. Shanghai ZJ Bio-Tech Corporation Information
Table 109. Shanghai ZJ Bio-Tech Description and Business Overview
Table 110. Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Product
Table 112. Shanghai ZJ Bio-Tech Recent Developments/Updates
Table 113. Shanghai Geneodx Biotech Corporation Information
Table 114. Shanghai Geneodx Biotech Description and Business Overview
Table 115. Shanghai Geneodx Biotech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Shanghai Geneodx Biotech 2019-nCoV Assay Kit Product
Table 117. Shanghai Geneodx Biotech Recent Developments/Updates
Table 118. INNOVITA Corporation Information
Table 119. INNOVITA Description and Business Overview
Table 120. INNOVITA 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. INNOVITA 2019-nCoV Assay Kit Product
Table 122. INNOVITA Recent Developments/Updates
Table 123. Genomics Biotech (Wuhan) Corporation Information
Table 124. Genomics Biotech (Wuhan) Description and Business Overview
Table 125. Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Product
Table 127. Genomics Biotech (Wuhan) Recent Developments/Updates
Table 128. Zhongshan Daan Gene Corporation Information
Table 129. Zhongshan Daan Gene Description and Business Overview
Table 130. Zhongshan Daan Gene 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Zhongshan Daan Gene 2019-nCoV Assay Kit Product
Table 132. Zhongshan Daan Gene Recent Developments/Updates
Table 133. Sanaure Corporation Information
Table 134. Sanaure Description and Business Overview
Table 135. Sanaure 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Sanaure 2019-nCoV Assay Kit Product
Table 137. Sanaure Recent Developments/Updates
Table 138. Shanghai Bio-Germ Corporation Information
Table 139. Shanghai Bio-Germ Description and Business Overview
Table 140. Shanghai Bio-Germ 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Shanghai Bio-Germ 2019-nCoV Assay Kit Product
Table 142. Shanghai Bio-Germ Recent Developments/Updates
Table 143. Guangzhou Wonfo Bio-Tech Corporation Information
Table 144. Guangzhou Wonfo Bio-Tech Description and Business Overview
Table 145. Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Product
Table 147. Guangzhou Wonfo Bio-Tech Recent Developments/Updates
Table 148. Chengdu Boaojing Bio-Tech Corporation Information
Table 149. Chengdu Boaojing Bio-Tech Description and Business Overview
Table 150. Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Product
Table 152. Chengdu Boaojing Bio-Tech Recent Developments/Updates
Table 153. Beijing XABT Corporation Information
Table 154. Beijing XABT Description and Business Overview
Table 155. Beijing XABT 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Beijing XABT 2019-nCoV Assay Kit Product
Table 157. Beijing XABT Recent Developments/Updates
Table 158. Bioscience(Chongqing) Bio-Tech Corporation Information
Table 159. Bioscience(Chongqing) Bio-Tech Description and Business Overview
Table 160. Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Product
Table 162. Bioscience(Chongqing) Bio-Tech Recent Developments/Updates
Table 163. Maccura Bio-Tech Corporation Information
Table 164. Maccura Bio-Tech Description and Business Overview
Table 165. Maccura Bio-Tech 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. Maccura Bio-Tech 2019-nCoV Assay Kit Product
Table 167. Maccura Bio-Tech Recent Developments/Updates
Table 168. Xiamen InnoDx Corporation Information
Table 169. Xiamen InnoDx Description and Business Overview
Table 170. Xiamen InnoDx 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 171. Xiamen InnoDx 2019-nCoV Assay Kit Product
Table 172. Xiamen InnoDx Recent Developments/Updates
Table 173. Guangdong Hecin-Scientific Corporation Information
Table 174. Guangdong Hecin-Scientific Description and Business Overview
Table 175. Guangdong Hecin-Scientific 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 176. Guangdong Hecin-Scientific 2019-nCoV Assay Kit Product
Table 177. Guangdong Hecin-Scientific Recent Developments/Updates
Table 178. Wuhan Easydiagnosis Biomedicine Corporation Information
Table 179. Wuhan Easydiagnosis Biomedicine Description and Business Overview
Table 180. Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 181. Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Product
Table 182. Wuhan Easydiagnosis Biomedicine Recent Developments/Updates
Table 183. Curative Corporation Information
Table 184. Curative Description and Business Overview
Table 185. Curative 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 186. Curative 2019-nCoV Assay Kit Product
Table 187. Curative Recent Developments/Updates
Table 188. Biolidics Corporation Information
Table 189. Biolidics Description and Business Overview
Table 190. Biolidics 2019-nCoV Assay Kit Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 191. Biolidics 2019-nCoV Assay Kit Product
Table 192. Biolidics Recent Developments/Updates
Table 193. Production Base and Market Concentration Rate of Raw Material
Table 194. Key Suppliers of Raw Materials
Table 195. 2019-nCoV Assay Kit Distributors List
Table 196. 2019-nCoV Assay Kit Customers List
Table 197. 2019-nCoV Assay Kit Market Trends
Table 198. 2019-nCoV Assay Kit Growth Drivers
Table 199. 2019-nCoV Assay Kit Market Restraints
Table 200. Global 2019-nCoV Assay Kit Sales Forecast by Type (2022-2027) & (K Units)
Table 201. Global 2019-nCoV Assay Kit Sales Market Share Forecast by Type (2022-2027)
Table 202. Global 2019-nCoV Assay Kit Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 203. Global 2019
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs